Dr. Kenneth Sharlin explores personalized MS treatment, BTK inhibitors, and when to use or stop disease-modifying therapies.
Dr. Kenneth Sharlin unpacks the latest in multiple sclerosis care, from cutting-edge BTK inhibitors to knowing when to stop disease-modifying therapies. He shares how age, disease stage, and immune activity impact treatment decisions—and why functional medicine, narrative, and neuro-fitness are vital for long-term success.
Dr. Kenneth Sharlin is a board-certified neurologist and functional medicine practitioner who blends conventional neurology with root-cause approaches to help patients with multiple sclerosis and neurodegenerative disorders. Through his Brain Tune-Up program and Shoreline Health & Neurology clinic, he integrates the latest science, diagnostic tools, and healing narratives to guide patients toward stability, strength, and meaningful recovery.
Website: https://functionalmedicine.doctor/
